_____________ Supporting Organ and Tissue Donation in Clinical Settings: The Pennsylvania Requirement
ORGAN PROCUREMENT ORGANIZATIONS OPOs are nonprofit organizations responsible for the coordi- nation of organ donation within a defined Donation Service Area (DSA). There are 58 OPOs in the United States, each designated by CMS [5]. In Pennsylvania, Gift of Life Donor Program serves the southeastern part of the state, while the Center for Organ Recovery and Education (CORE) serves the western and central regions [6]. OPOs employ specialized staff including donation coordinators, family support coordinators, and medical directors who work directly with hospital teams. When a potential donor is identified, the OPO is responsible for evaluating medical suitability, obtaining authorization, coordinating surgical procurement, and facilitating the place- ment of recovered organs with waiting recipients through UNOS. WHO CAN DONATE? A common misconception among both the public and health- care providers is that significant medical history automatically disqualifies someone from donation. In reality, very few abso- lute contraindications to donation exist. Active, untreated sepsis involving a specific organ, active metastatic cancer (with some exceptions), and certain transmissible infections such as untreated Ebola or rabies represent examples of true contraindications. For all other potential donors, including those with cancer history, diabetes, hypertension, hepatitis, or advanced age, the OPO’s medical director makes the final determination on a case-by-case basis [7]. Clinicians should never independently rule out a patient as a potential donor; that determination belongs exclusively to the OPO. THE TRANSPLANT WAITING LIST Patients in need of transplant are listed with UNOS by their transplant center. Allocation algorithms factor in medical urgency, time on the waiting list, geographic proximity to the donor, blood type compatibility, and, for some organs, antigen matching. The goal is to maximize both equity and utility. Continuous policy refinements by OPTN have sought to reduce geographic disparities in organ allocation, most nota- bly through the adoption of continuous distribution models beginning in 2022 for hearts and lungs [8]. Pennsylvania has one of the nation’s largest populations on transplant waiting lists [6]. Act 90 mandates that all hospi- tals in the state have written protocols, known as Required Request Protocols, ensuring that families of patients who die or are declared brain dead are offered the option of donation. Pennsylvania also enacted an opt-in donor registry through PennDOT, with registration options available at driver’s license renewal and online through the Donate Life PA registry [9].
INTRODUCTION Every day in the United States, approximately 13 people die waiting for an organ transplant. As of early 2026, more than 100,000 individuals remain on the national transplant waiting list, and a new name is added every 8 minutes [1]. In Pennsylvania alone, more than 6,000 residents are awaiting lifesaving transplants, yet the gap between supply and demand persists—not solely due to a lack of willing donors, but often because of missed opportunities within the clinical setting [2]. Pennsylvania law, under Act 90 of 2018, mandates that licensed nurses and physicians receive education in organ and tissue donation as part of their continuing education requirements. This course fulfills that obligation. Its purpose is not merely reg- ulatory compliance; it is to equip the bedside clinician with the knowledge, confidence, and communication skills to identify potential donors, support grieving families, collaborate with procurement organizations, and deliver compassionate care at one of the most sensitive moments in the human experience. OVERVIEW OF THE ORGAN DONATION AND TRANSPLANTATION SYSTEM The U.S. organ donation and transplantation system is a coor- dinated national infrastructure governed by federal law, oper- ated by a network of public and private entities, and grounded in the principle of equitable access to lifesaving treatment. LEGISLATIVE AND REGULATORY FOUNDATION The National Organ Transplant Act (NOTA) of 1984 estab- lished the legal framework for the modern transplant system. NOTA created the Organ Procurement and Transplantation Network (OPTN), a unified national network currently oper- ated under contract by the United Network for Organ Sharing (UNOS). OPTN establishes the policies that govern organ allocation, matching, and distribution across the country [3]. NOTA also prohibited the sale of human organs, establishing organ donation as an act of voluntary altruism. The U.S. Department of Health and Human Services (HHS) oversees the national system through HRSA’s Division of Transplantation. The Centers for Medicare and Medicaid Services (CMS) conditions of participation require hospitals to have agreements with their designated organ procurement organization (OPO) and to refer all deaths and imminent deaths to that OPO in a timely fashion [4].
56
MDPA2326
Powered by FlippingBook